Cribstone Capital Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$20K Hold
296
0.01% 208
2022
Q3
$15K Hold
296
0.01% 224
2022
Q2
$16K Sell
296
-8
-3% -$444 0.01% 220
2022
Q1
$17K Buy
304
+8
+3% +$411 0.01% 231
2021
Q4
$17K Hold
296
0.01% 229
2021
Q3
$14K Hold
296
0.01% 228
2021
Q2
$12K Buy
296
+156
+111% +$6.05K 0.01% 250
2021
Q1
$5K Buy
+140
New +$4.99K ﹤0.01% 284
2019
Q4
Sell
-4,070
Closed -$105K 481
2019
Q3
$105K Sell
4,070
-200
-5% -$5.06K 0.06% 148
2019
Q2
$109K Hold
4,270
0.06% 155
2019
Q1
$112K Hold
4,270
0.06% 155
2018
Q4
$98K Hold
4,270
0.05% 176
2018
Q3
$101K Hold
4,270
0.05% 190
2018
Q2
$98K Hold
4,270
0.05% 195
2018
Q1
$105K Hold
4,270
0.05% 186
2017
Q4
$115K Sell
4,270
-60
-1% -$1.53K 0.05% 197
2017
Q3
$104K Sell
4,330
-186
-4% -$4.2K 0.05% 171
2017
Q2
$97K Sell
4,516
-186
-4% -$3.75K 0.05% 185
2017
Q1
$83K Hold
4,702
0.05% 218
2016
Q4
$84K Sell
4,702
-1,228
-21% -$22.3K 0.05% 194
2016
Q3
$118K Hold
5,930
0.07% 157
2016
Q2
$159K Buy
+5,930
New +$163K 0.1% 126

Other funds holding NVO

Cribstone Capital Management's NVO Position: Q4 2022 in Review

Cribstone Capital Management held its Novo Nordisk (NVO) position steady in Q4 2022 at 296 shares worth $20K. The position accounts for 0.01% of the portfolio, ranked #208.

Cribstone Capital Management first reported a position in NVO in Q2 2016 and has held it in 22 quarters since. The position peaked at $159K in Q2 2016. 1,049 funds tracked by Wall St. Rank hold NVO as of Q4 2022.

  • Cribstone Capital Management held 296 shares of Novo Nordisk worth $20K as of Q4 2022.
  • Cribstone Capital Management left its Novo Nordisk share count unchanged in Q4 2022.
  • Novo Nordisk made up 0.01% of Cribstone Capital Management's portfolio in Q4 2022, its #208 holding.
  • Cribstone Capital Management first reported a position in Novo Nordisk in Q2 2016 and has held it in 22 quarters since.
  • Cribstone Capital Management's Novo Nordisk position peaked at $159K in Q2 2016.
  • 1,049 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2022.

Based on Cribstone Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.